BBLG · Bone Biologics Corp
United States · RS rating 3 · As of 2026-10-14
| Price | 0.41 USD |
|---|---|
| 1-day change | -3.6% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 9 / 3 / 5 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 5 / 15 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +84.4% |
| Market cap (USD) | $2.4M |